DR Reddys Laboratories Ltd (RDY)
Dr. Reddy's makes generic medicines, active pharmaceutical ingredients and consumer healthcare products. It last closed at $14.80 on Nov 17, up 0.68% on the day. RDY reports earnings on Fri, Jan 22, 2027. In the past 30 days there were 1 dark pool print totaling $3.0M, the largest $3.0M.
Key Stats
Fiscal 2025Not reported for this period.
From RDY's SEC filings, latest 20-F for the period ending Mar 31, 2025 (filed May 29). Per share figures are left out because the US listing can represent a different number of shares.
Earnings
Full earnings history →Analyst Ratings & Price Targets
Analyst Ratings →Based on 1 analyst who set a price target on RDY in the past 90 days. The average target is $1450.00, with a high of $1450.00 and a low of $1450.00, compared with the last close of $14.80.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 29 | Citigroup | Upgrade | Buy | $1450 |
Technical Analysis
The stock is 3% above its 20 day and 11% above its 50 day average. It is 10% above its 200 day average, so the longer trend is still up. Momentum is improving (RSI 70), near overbought. The nearest support is the Pivot S1 at $14.73, and the nearest resistance the Pivot at $14.83.
| RSI (14) | 69.72 | Strong, overbought above 70 | Neutral |
| MACD | 0.50 | Below its signal line | Bearish |
| Stochastic | 74.6 | Middle of its range | Neutral |
| ADX (14) | 40.7 | Strong uptrend | |
| Williams %R | -26.8 | Oversold below −80, overbought above −20 | Neutral |
| CCI (20) | 73.6 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | +3.4% | Change over 10 sessions | Bullish |
| ATR (14) | $0.28 | Typical daily range, 1.9% of price |
| RSI (14) | 67.08 | Strong, overbought above 70 | Neutral |
| MACD | 0.31 | Above its signal line | Bullish |
| Stochastic | 94.3 | Near the top of its range | Overbought |
| ADX (14) | 21.1 | Weak trend | |
| Williams %R | -7.7 | Oversold below −80, overbought above −20 | Overbought |
| CCI (20) | 158.2 | Oversold below −100, overbought above 100 | Overbought |
| Rate of change | +24.4% | Change over 10 sessions | Bullish |
| ATR (14) | $0.68 | Typical daily range, 4.6% of price |
What happened before
See how RDY did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How RDY has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
Whale Options Flow
90DNo whale options trades in RDY in the last 90 days.
Dark Pool
30DRDY Institutional Ownership
Full report →- ▼87 buying vs 131 selling
- ▼Shares held by funds -4.8%
- ▼Funds holding -7
- ▲Superinvestors: 3 added, 1 cut
- ●Put/call not meaningful
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 232 | 239 | −2.9% |
| In funds' top 10 | 1 | 1 | 0.0% |
| Held by funds | – | – | – |
| New / increased | 25 / 62 | 28 / 77 | −17.1% |
| Reduced / sold out | 100 / 31 | 95 / 37 | −0.8% |
| Put/call ratio | – | – | – |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RDY is in one of them and how their past RDY trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered RDY in an article yet. Here's the latest on the wider market.
About DR Reddys Laboratories
Dr. Reddy's is a pharmaceutical company based in Hyderabad, India. It makes and sells generic medicines, both branded and unbranded, along with biosimilars and consumer healthcare products. It also manufactures active pharmaceutical ingredients, the core ingredients used in finished medicines, and offers contract research and manufacturing services to other drug companies. Its key markets include the United States, India, Russia, other former Soviet countries and Europe.
- Headquarters
- Hyderabad
- Founded
- 1984
- Website
- drreddys.com ↗



